Nothing Special   »   [go: up one dir, main page]

MX2017001512A - Compuestos activos hacia bromodominios. - Google Patents

Compuestos activos hacia bromodominios.

Info

Publication number
MX2017001512A
MX2017001512A MX2017001512A MX2017001512A MX2017001512A MX 2017001512 A MX2017001512 A MX 2017001512A MX 2017001512 A MX2017001512 A MX 2017001512A MX 2017001512 A MX2017001512 A MX 2017001512A MX 2017001512 A MX2017001512 A MX 2017001512A
Authority
MX
Mexico
Prior art keywords
bromodomains
compounds active
active towards
compounds
towards
Prior art date
Application number
MX2017001512A
Other languages
English (en)
Inventor
GERNER SEITZBERG Jimmi
Titilola Akinleminu Kronborg Tine
Teuber Lene
Poljak Visnja
FRIBERG Gitte
Original Assignee
Nuevolution As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuevolution As filed Critical Nuevolution As
Priority claimed from PCT/EP2015/067400 external-priority patent/WO2016016316A1/en
Publication of MX2017001512A publication Critical patent/MX2017001512A/es

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se divulgan compuestos dirigidos a bromodominios, composiciones farmacéuticas que contienen los compuestos, y el uso de los compuestos en tratamientos.
MX2017001512A 2014-08-01 2015-07-29 Compuestos activos hacia bromodominios. MX2017001512A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1450919A 2014-08-01 2014-08-01
PCT/EP2015/067400 WO2016016316A1 (en) 2014-08-01 2015-07-29 Compounds active towards bromodomains

Publications (1)

Publication Number Publication Date
MX2017001512A true MX2017001512A (es) 2017-07-24

Family

ID=59872162

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017001512A MX2017001512A (es) 2014-08-01 2015-07-29 Compuestos activos hacia bromodominios.

Country Status (1)

Country Link
MX (1) MX2017001512A (es)

Similar Documents

Publication Publication Date Title
MY187540A (en) Compounds active towards bromodomains
MX2023008686A (es) Polinucleotidos moduladores.
MX2020009780A (es) Compuestos de inhibidor de autotaxina.
GB2541571A (en) Pharmaceutical compositions
MX2015009106A (es) Composiciones de solución sólida y su uso en el tratamiento del dolor intenso.
MX2017002489A (es) Agentes terapeuticos humanos.
MX2017004808A (es) Combinaciones que comprenden siponimod y laquinimod para el tratamiento de la esclerosis multiple.
SG11201605868XA (en) Pharmaceutical composition for cancer treatment and pharmaceutical preparation for cancer treatment containing same composition as active ingredient
IL252897A0 (en) Indanyl compounds, pharmaceutical preparations and their medical uses
PH12017500348B1 (en) Tetrahydroquinoline derivatives as bromodomain inhibitors
AU2018253600A1 (en) Dosage forms and therapeutic uses of l-4-chlorokynurenine
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
MX2017014456A (es) Usos terapeuticos de l-4-cloroquinurenina.
MX2018005987A (es) Compuestos heterociclicos para el tratamiento de enfermedades.
TW201713323A (en) Therapeutic compositions and methods of use thereof
PH12016501838A1 (en) Compounds and their methods of use
MX368268B (es) Formulacion de atazanavir y cobicistat para el tratamiento del virus de inmunodeficiencia humana (vih).
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
GB201406172D0 (en) Therapy and pharmaceutical composition
GB201519644D0 (en) Therapy and pharmaceutical composition
MX2017001512A (es) Compuestos activos hacia bromodominios.
PH12020500472A1 (en) Autotaxin inhibitor compounds
EP3384900A4 (en) STABILIZED GALENIC FORM OF A CONJUGATE OF ETHYDRONATE WITH CITRABINE AND USE THEREOF
GB2546703A (en) Compounds